Bio-Bridge Science Inc BGES:Over The Counter Market

Last Price$0.0050Over The Counter Market Previous Close - Last Trade as of 9:31AM ET 9/27/21
Over The Counter Market 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$0.0030 (10,000)
Ask (Size)$0.02 (10,000)
Day Low / HighN/A - N/A
Volume42.8 K

View Biotechnology IndustryPeer Comparison as of 09/27/2021


Bio-Bridge Science Inc ( OTC )

Price: $0.005
Change: 0.00 (0.00%)
Volume: 42.8 K
9:31AM ET 9/27/2021

Pathfinder Cell Therapy Inc ( OTC )

Price: $0.00
Change: 0.00 (0.00%)
Volume: 700.00
12:09PM ET 11/10/2021

DNAPrint Genomics Inc ( OTC )

Price: $0.00
Change: 0.00 (0.00%)
Volume: 250.00
3:52PM ET 11/22/2021

Alseres Pharmaceuticals Inc ( OTC )

Price: $0.01
Change: 0.00 (0.00%)
Volume: 2.00
11:53AM ET 11/10/2021

Spencer Pharmaceutical Inc ( OTC )

Price: $0.0002
Change: 0.00 (0.00%)
Volume: 450.00
11:17AM ET 9/24/2021

Read more news Recent News

No news stories available at this time.

Company Profile

Business DescriptionBio-Bridge Science, Inc. operates as a biotechnology company. It focuses on the commercial development of HIV-PV Vaccine I, HPV vaccine, colon cancer vaccine, mucosal adjuvant and the manufacture and sale of vaccine production-related materials. The company was founded by Wenhui Qiao, Liang Qiao, Shyh-Jing Chiang and Isao Arimoto on October 26, 2004 and is headquartered in Oakbrook Terrace, IL. View company web site for more details
Address1801 South Meyers Road
Oakbrook Terrace, Illinois 60181
Number of Employees23

Company Highlights

Price Open$0.02
Previous Close$0.005
52 Week Range$0.005 - 0.15
Market Capitalization$230.7 K
Shares Outstanding46.1 M
SectorHealth Technology
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.04
Beta vs. S&P 500N/A
Revenue$97.1 K
Net Profit Margin-3,511.99%
Return on Equity-63.99%